167 related articles for article (PubMed ID: 24475255)
1. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: retrospective study of the Milan and Hangzhou criteria.
Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
PLoS One; 2014; 9(1):e87222. PubMed ID: 24475255
[TBL] [Abstract][Full Text] [Related]
2. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
[TBL] [Abstract][Full Text] [Related]
3. Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection.
Hu Z; Zhou J; Xu X; Li Z; Zhou L; Wu J; Zhang M; Zheng S
PLoS One; 2012; 7(5):e36587. PubMed ID: 22574187
[TBL] [Abstract][Full Text] [Related]
4. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
Wu L; Hu A; Tam N; Zhang J; Lin M; Guo Z; He X
PLoS One; 2012; 7(7):e41820. PubMed ID: 22848619
[TBL] [Abstract][Full Text] [Related]
5. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.
Liu F; Wei Y; Wang W; Chen K; Yan L; Wen T; Zhao J; Xu M; Li B
PLoS One; 2012; 7(11):e48932. PubMed ID: 23145027
[TBL] [Abstract][Full Text] [Related]
6. Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.
Zhang HM; Jiang WT; Pan C; Deng YL; Zheng H; Shen ZY
Transplant Proc; 2015 Mar; 47(2):438-44. PubMed ID: 25769587
[TBL] [Abstract][Full Text] [Related]
7. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Qu Z; Ling Q; Gwiasda J; Xu X; Schrem H; Beneke J; Kaltenborn A; Krauth C; Mix H; Klempnauer J; Emmanouilidis N
Langenbecks Arch Surg; 2018 Aug; 403(5):643-654. PubMed ID: 30120543
[TBL] [Abstract][Full Text] [Related]
8. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
[TBL] [Abstract][Full Text] [Related]
9. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
[TBL] [Abstract][Full Text] [Related]
10. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
Al-Ameri AAM; Wei X; Liu P; Lin L; Shao Z; Xie H; Zhou L; Zheng S; Xu X
Ann Transplant; 2019 Aug; 24():489-498. PubMed ID: 31427563
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
[TBL] [Abstract][Full Text] [Related]
13. Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria.
Gao T; Xia Q; Qiu DK; Feng YY; Chi JC; Wang SY; Xi ZF; Zhang JJ; Xu N; Chen SY; Qiu YL; Shen LW; Zhou TT; Dong XJ; Li QG; Li H
J Dig Dis; 2013 Oct; 14(10):552-8. PubMed ID: 23782458
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center Experience.
Lyu SC; Wang J; Ren ZY; Cao D; He Q
Curr Med Sci; 2022 Jun; 42(3):548-554. PubMed ID: 35391617
[TBL] [Abstract][Full Text] [Related]
17. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
[TBL] [Abstract][Full Text] [Related]
18. Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection.
Liang BY; Huang ZY; Zhou SJ; Hou P; Wang SF; Jiang B; Chen XP
Hepatogastroenterology; 2014 Oct; 61(135):2014-20. PubMed ID: 25713904
[TBL] [Abstract][Full Text] [Related]
19. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis.
Li HY; Wei YG; Yan LN; Li B
World J Gastroenterol; 2012 May; 18(19):2415-22. PubMed ID: 22654435
[TBL] [Abstract][Full Text] [Related]
20. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
